- Home
- TELA vs BRNS Comparison
TELA vs BRNS Comparison
Compare TELA & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- BRNS
- Stock Information
- Founded
- TELA 2012
- BRNS 2016
- Country
- TELA United States
- BRNS United Kingdom
- Employees
- TELA N/A
- BRNS N/A
- Industry
- TELA Medical/Dental Instruments
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- TELA Health Care
- BRNS Health Care
- Exchange
- TELA Nasdaq
- BRNS Nasdaq
- Market Cap
- TELA 36.4M
- BRNS 36.0M
- IPO Year
- TELA 2019
- BRNS 2021
- Fundamental
- Price
- TELA $1.93
- BRNS $0.92
- Analyst Decision
- TELA Strong Buy
- BRNS Strong Buy
- Analyst Count
- TELA 4
- BRNS 1
- Target Price
- TELA $6.00
- BRNS $3.00
- AVG Volume (30 Days)
- TELA 86.9K
- BRNS 13.5K
- Earning Date
- TELA 08-11-2025
- BRNS 08-07-2025
- Dividend Yield
- TELA N/A
- BRNS N/A
- EPS Growth
- TELA N/A
- BRNS N/A
- EPS
- TELA N/A
- BRNS N/A
- Revenue
- TELA $71,217,000.00
- BRNS $14,969,000.00
- Revenue This Year
- TELA $26.67
- BRNS N/A
- Revenue Next Year
- TELA $22.63
- BRNS N/A
- P/E Ratio
- TELA N/A
- BRNS N/A
- Revenue Growth
- TELA 12.78
- BRNS 4381.74
- 52 Week Low
- TELA $0.86
- BRNS $0.64
- 52 Week High
- TELA $5.18
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- TELA 59.11
- BRNS 51.07
- Support Level
- TELA $1.85
- BRNS $0.90
- Resistance Level
- TELA $1.94
- BRNS $0.94
- Average True Range (ATR)
- TELA 0.19
- BRNS 0.06
- MACD
- TELA -0.00
- BRNS 0.00
- Stochastic Oscillator
- TELA 72.58
- BRNS 58.51
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.